spot difference
  • Sign In
  • Register
  • Cart (0)
Home > References > 2017 > A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo

A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo

S Hipp, Y-T Tai, D Blanset, P Deegen, J Wahl, O Thomas, B Rattel, P J Adam, K C Anderson and M Friedrich
Journal   Leukemia
Species  
Analytes Measured  
Matrix Tested  
Year   2017
Volume   31
Page Numbers   1743-1751
Application   Oncology and Cancer

View Publications
View Publications

Related Products

V-PLEX Human IL-2 Kit
IL-2 | Human
Singleplex
NEW
V-PLEX Human IL-12p70 Kit
IL-12p70 | Human
Singleplex
NEW
V-PLEX Human IL-8 Kit
IL-8 | Human
Singleplex
NEW
V-PLEX Human IFN-γ Kit
IFN-γ | Human
Singleplex
NEW
V-PLEX Human IL-6 Kit
IL-6 | Human
Singleplex
NEW
V-PLEX Human IL-1β Kit
IL-1β | Human
Singleplex
NEW
V-PLEX Human IL-10 Kit
IL-10 | Human
Singleplex
NEW
V-PLEX Human TNF-α Kit
TNF-α | Human
Singleplex
NEW
V-PLEX Human IL-4 Kit
IL-4 | Human
Singleplex
NEW
V-PLEX Human IL-13 Kit
IL-13 | Human
Singleplex
NEW
V-PLEX Proinflammatory Panel 1 Human Kit
IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, TNF-α | Human
Multiplex
NEW
Browse Our Products

By Analytes
By Applications
Search
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters